Search

Dr. Mini Kamboj, MSK’s Chief Medical Epidemiologist, explains what people with cancer and their caregivers need to know about measles and the MMR (measles, mumps, and rubella) vaccine.

… Monday, February 9, 2026 More than 25 years ago, public health officials declared that measles had been eliminated in the United States. Today, however, due to declining vaccination rates, measles cases have surged to their highest levels in decades. Mini Kamboj, MD , MSK’s Chief Medical Epidemiologist

… Wednesday, March 10, 2010 Team GSK Raises Money for Rare Cancer Research Dimiter Tassev Team GSK Captain Dimiter Tassev On Feburary 6, teams of Gerstner Sloan Kettering students and faculty joined 2,500 indoor cyclists from New York and Chicago to raise more than $2.4 million to support rare cancer research

The list acknowledges and celebrates healthcare leaders who envision a better future for all New Yorkers and constitute New York’s ever-expanding and constantly improving healthcare system.

… Monday, October 31, 2022 Selwyn M. Vickers, M.D., FACS , President and CEO of Memorial Sloan Kettering Cancer Center (MSK), has been named to amNY Metro  and  PoliticsNY ’s Power Players in Healthcare list. The list acknowledges and celebrates healthcare leaders who envision a better future for all New

Memorial Sloan Kettering Cancer Center (MSK) announces the November 2022 awards and appointments.

… Thursday, December 1, 2022 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Tania Bubb Tania Bubb Elected President of The Association for Professionals in Infection Control and Epidemiology Tania Bubb, PhD, RN, Senior Director of Infection Control, has been

New findings on several important lung cancer clinical trials were presented at the 2025 Annual Meeting of the American Society of Clinical Oncology.

… Monday, June 2, 2025 Researchers from Memorial Sloan Kettering Cancer Center (MSK) reported important advances in the treatment of lung cancer  at the annual meeting of the American Society of Clinical Oncology (ASCO), held May 30 to June 3 in Chicago. Scientists presented promising results on three

Dr. Miles is a postdoctoral fellow in the Human Oncology and Pathogenesis Program at MSK studying the genetics of blood cancers.

… Monday, June 8, 2020 Summary Linde Miles is a postdoctoral fellow in the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering. She is a 2020 winner of a Kravis Women in Science Endeavor (WiSE) Postdoctoral Fellowship . Dr. Miles will be presenting her research at the inaugural Kravis WISE

Metastasis — the spreading of cancer from its original location to a new location — can be broken down into three main stages: dissemination, dormancy, and outbreak.

… Thursday, July 1, 2021 Illustration explaining the stages of cancer metastasis Click to enlarge » Metastasis — the spreading of cancer from its original location to a new location — can be broken down into three main stages: dissemination, dormancy, and outbreak. Memorial Sloan Kettering researchers

Recent studies have raised the possibility that coffee might protect against colorectal cancer. MSK surgeon Garrett Nash advises against jumping to conclusions.

… Friday, March 22, 2019 Summary Researchers have long pondered a possible link between drinking coffee and cancer risk. The evidence has been confusing and largely inconclusive. In recent years, intriguing research has suggested that drinking coffee might protect against colorectal cancer. A study published

Integrative medicine specialists determine which complementary therapies appear to be most effective.

… Thursday, May 18, 2017 Summary Though many people with cancer use complementary therapies, there is still some debate about which practices are truly effective. A new study suggests that mind-body therapies, such as meditation and yoga, have the best track record. Studies indicate that many people with

In October 2009, a team of eight researchers, six of whom are at Memorial Sloan Kettering, received an $11 million, five-year grant from the NCI to form one of 12 Physical Sciences-Oncology Centers (PS-OCs) in the United States.

… Monday, February 1, 2010 Summary In October 2009, a team of eight researchers, six of whom are at Memorial Sloan Kettering, received an $11 million, five-year grant from the NCI to form one of 12 Physical Sciences-Oncology Centers (PS-OCs) in the United States. People don’t usually think of math when